Does Rallies show 13F holders for PRVA?

Yes. Rallies tracks hedge fund and 13F ownership data for PRVA, including fund names, share counts, latest tracked quarter, and position changes when available.

Is PRVA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PRVA. It does not provide personalized investment advice.

PRVA (Privia Health Group, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings

Privia Health Group, Inc. Common Stock (PRVA) is a publicly traded Healthcare sector company. As of May 21, 2026, PRVA trades at $23.19 with a market cap of $2.99B and a P/E ratio of 128.57. PRVA moved -0.43% today. Year to date, PRVA is -3.98%; over the trailing twelve months it is -5.46%. Its 52-week range spans $16.47 to $26.51. Analyst consensus is strong buy with an average price target of $31.33. Rallies surfaces PRVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns PRVA stock?

Hedge funds tracked by Rallies that own PRVA include Blackbarn Capital, Soros Fund, Bridgewater Associates, Eisler Capital, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Privia Health Group, Inc. Common Stock.

PRVA Key Metrics

Key financial metrics for PRVA
Metric	Value
Price	$23.19
Market Cap	$2.99B
P/E Ratio	128.57
EPS	$0.18
Dividend Yield	0.00%
52-Week High	$26.51
52-Week Low	$16.47
Volume	440.41K
Avg Volume	0
Revenue (TTM)	$2.25B
Net Income	$27.39M
Gross Margin	0.00%

Top Hedge Funds Holding PRVA

Blackbarn Capital holds 1.58M shares of PRVA, changed +21.92% as of Mar 31, 2026.
Soros Fund holds 700.00K shares of PRVA, changed -6.67% as of Dec 31, 2024.
Bridgewater Associates holds 237.95K shares of PRVA, changed +13.30% as of Mar 31, 2026.
Eisler Capital holds 48.12K shares of PRVA, changed +0.00% as of Jun 30, 2024.
Mangrove Partners holds 27.15K shares of PRVA, changed +0.00% as of Mar 31, 2026.

Latest PRVA News

Privia Health Q1 Revenue Jumps 25.8% to $603.8 M with EBITDA Up 36.3% — May 7, 2026
Privia Health Q1 Revenue Seen at $580.65M, EPS $0.08; Full-Year Forecast Upgraded — May 6, 2026
Privia Health Earns 2026 HFMA MAP Award, Ninth Win in Ten Years — Mar 24, 2026
Analysts Project 25.5% Upside for Privia Health as PPI Surge Weighs on Shares — Feb 27, 2026
Privia Health Q4 Collections Rise 9.6% to $868.7M, EBITDA Jumps 26.4% — Feb 27, 2026

Recent PRVA Insider Trades

Mehrotra Parth sold 15.65K (~$354.25K) on May 12, 2026.
Mehrotra Parth sold 105.44K (~$2.38M) on May 11, 2026.
Mountcastle David sold 3.38K (~$76.50K) on May 11, 2026.

PRVA Analyst Consensus

15 analysts cover PRVA: 0 strong buy, 14 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $31.33.

Common questions about PRVA

Who owns PRVA stock?: Hedge funds tracked by Rallies that own PRVA include Blackbarn Capital, Soros Fund, Bridgewater Associates, Eisler Capital, and Mangrove Partners. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Privia Health Group, Inc. Common Stock.
Does Rallies show 13F holders for PRVA?: Yes. Rallies tracks hedge fund and 13F ownership data for PRVA, including fund names, share counts, latest tracked quarter, and position changes when available.
Is PRVA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PRVA. It does not provide personalized investment advice.